Clal Industries

Clal Industries is a prominent Israeli holding company and investment firm, wholly owned by the global private group Access Industries. The company maintains a diverse portfolio across several sectors, with a significant and strategic focus on the life sciences through its subsidiary, Clal Biotechnology Industries (CBI). As one of Israel's largest life sciences investment groups, Clal Industries manages a portfolio of companies focused on high-impact areas such as oncology, regenerative medicine, and infectious diseases. Key holdings include companies like MediWound, which specializes in enzymatic burn treatment, and Gamida Cell, a pioneer in cell therapy for blood cancers. The firm provides essential capital, strategic management, and global networking to help its portfolio companies navigate the clinical and regulatory path to commercialization.